advertisement

---

Wang JW 16

Showing records 1 to 16 | Display all abstracts from Wang JW

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Coleman RA
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodward DF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Coleman RA; Woodrooffe AJ; Woodrooffe AJ
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Wang JW; Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Clark KL
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Clark KL
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ; Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Toris CB
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Clark KL
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Fan S
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Clark KL
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Wang JW
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Stamer WD; Tao G
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Woodward DF
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Fan S; Toris CB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---